期刊： CANCER COMMUNICATIONS, 2021; 41 (9)
Cancer immunotherapy, especially immune checkpoint blockade (ICB), has revolutionized oncology. However, only a limited number of patients benefit fro......
期刊： CANCER COMMUNICATIONS, 2021; 41 (9)
Cancer greatly affects the quality of life of humans worldwide and the number of patients suffering from it is continuously increasing. Over the last ......
期刊： CANCER COMMUNICATIONS, 2021; 41 (8)
Background Mitochondria are key regulators in cell proliferation and apoptosis. Alterations in mitochondrial function are closely associated with infl......
期刊： CANCER COMMUNICATIONS, 2021; 41 (7)
Background Multiple myeloma (MM) is a hematologic malignancy characterized by the accumulation of aberrant plasma cells within the bone marrow. The hi......
期刊： CANCER COMMUNICATIONS, 2021; 41 (9)
Background Increasing studies have reported that oncogenes regulate components of the immune system, suggesting that this is a mechanism for tumorigen......
期刊： CANCER COMMUNICATIONS, 2021; 41 (8)
Background Risk-stratified endoscopic screening (RSES), which offers endoscopy to those with a high risk of esophageal cancer, has the potential to in......
期刊： CANCER COMMUNICATIONS, 2021; 41 (6)
BackgroundConsidering the increase in the proportion of lung adenocarcinoma (LUAD) cases among all lung cancers and its considerable contribution to c......
期刊： CANCER COMMUNICATIONS, 2021; 41 (7)
Background: As a rate-limiting enzyme of glycolysis, pyruvate kinase muscle isozyme M2 (PKM2) participates in tumor metabolism and growth. The regulat......
期刊： CANCER COMMUNICATIONS, 2021; 41 (9)
Background Heterogeneity of leukemia-initiating cells (LICs) is a major obstacle in acute myeloid leukemia (AML) therapy. Accumulated evidence indicat......
期刊： CANCER COMMUNICATIONS, 2021; 41 (6)
Background Although programmed cell death-ligand 1 (PD-L1) plays a well-known function in immune checkpoint response by interacting with programmed ce......
期刊： CANCER COMMUNICATIONS, 2021; 41 (4)
Lung cancer mortality has decreased over the past decade and can be partly attributed to advances in targeted therapy and immunotherapy. Immune checkp......
期刊： CANCER COMMUNICATIONS, 2021; 41 (9)
Background Previous studies have demonstrated the preclinical pharmacological and toxicological consistency, and clinical pharmacokinetic equivalence ......
期刊： CANCER COMMUNICATIONS, 2021; 41 (8)
Background Colorectal cancer (CRC) is one of the most malignant tumors with high incidence, yet its molecular mechanism is not fully understood, hinde......
